South Korea · Delayed Price · Currency is KRW Bio Port Korea Statistics
Total Valuation
Bio Port Korea has a market cap or net worth of KRW 23.52 billion. The enterprise value is 19.90 billion.
| Market Cap | 23.52B |
| Enterprise Value | 19.90B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Port Korea has 4.61 million shares outstanding. The number of shares has increased by 6.36% in one year.
| Current Share Class | 4.61M |
| Shares Outstanding | 4.61M |
| Shares Change (YoY) | +6.36% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 48.77% |
| Owned by Institutions (%) | 0.46% |
| Float | 1.56M |
Valuation Ratios
The trailing PE ratio is 7.80.
| PE Ratio | 7.80 |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.72 |
| EV / Sales | 0.26 |
| EV / EBITDA | 3.99 |
| EV / EBIT | 8.31 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.40.
| Current Ratio | 2.06 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 3.37 |
| Debt / FCF | -2.60 |
| Interest Coverage | 9.64 |
Financial Efficiency
Return on equity (ROE) is 7.34% and return on invested capital (ROIC) is 6.17%.
| Return on Equity (ROE) | 7.34% |
| Return on Assets (ROA) | 2.43% |
| Return on Invested Capital (ROIC) | 6.17% |
| Return on Capital Employed (ROCE) | 5.31% |
| Weighted Average Cost of Capital (WACC) | 2.74% |
| Revenue Per Employee | 728.73M |
| Profits Per Employee | 27.69M |
| Employee Count | 107 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 8.67 |
Taxes
| Income Tax | -207.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.75% in the last 52 weeks. The beta is -0.05, so Bio Port Korea's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -63.75% |
| 50-Day Moving Average | 4,915.50 |
| 200-Day Moving Average | 6,333.68 |
| Relative Strength Index (RSI) | 52.70 |
| Average Volume (20 Days) | 9,658 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Port Korea had revenue of KRW 77.97 billion and earned 2.96 billion in profits. Earnings per share was 654.00.
| Revenue | 77.97B |
| Gross Profit | 19.43B |
| Operating Income | 2.39B |
| Pretax Income | 2.76B |
| Net Income | 2.96B |
| EBITDA | 4.99B |
| EBIT | 2.39B |
| Earnings Per Share (EPS) | 654.00 |
Balance Sheet
The company has 20.47 billion in cash and 16.85 billion in debt, with a net cash position of 3.62 billion or 784.30 per share.
| Cash & Cash Equivalents | 20.47B |
| Total Debt | 16.85B |
| Net Cash | 3.62B |
| Net Cash Per Share | 784.30 |
| Equity (Book Value) | 42.32B |
| Book Value Per Share | 9,204.01 |
| Working Capital | 22.31B |
Cash Flow
In the last 12 months, operating cash flow was -1.77 billion and capital expenditures -4.71 billion, giving a free cash flow of -6.48 billion.
| Operating Cash Flow | -1.77B |
| Capital Expenditures | -4.71B |
| Depreciation & Amortization | 2.60B |
| Net Borrowing | 4.68B |
| Free Cash Flow | -6.48B |
| FCF Per Share | -1,405.19 |
Margins
Gross margin is 24.92%, with operating and profit margins of 3.07% and 3.80%.
| Gross Margin | 24.92% |
| Operating Margin | 3.07% |
| Pretax Margin | 3.53% |
| Profit Margin | 3.80% |
| EBITDA Margin | 6.40% |
| EBIT Margin | 3.07% |
| FCF Margin | n/a |
Dividends & Yields
Bio Port Korea does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.36% |
| Shareholder Yield | -6.36% |
| Earnings Yield | 12.60% |
| FCF Yield | -27.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 16, 2025. It was a reverse split with a ratio of 0.1486215.
| Last Split Date | May 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1486215 |
Scores
Bio Port Korea has an Altman Z-Score of 3.15 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.15 |
| Piotroski F-Score | 3 |